jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Sickling Test

Blood
image

Report in 12Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Evaluates whether hemoglobin S (HbS) is present by inducing low oxygen conditions that cause sickling of RBCs

149350

57% OFF

Sickling Test - Comprehensive Medical Information Guide

  • Why is it done?
    • Test Purpose: Detects the presence of hemoglobin S (HbS), the abnormal hemoglobin associated with sickle cell disease and sickle cell trait. The test identifies whether red blood cells will assume a characteristic sickle (crescent) shape when exposed to low oxygen conditions.
    • Primary Indications: Newborn screening programs (routine testing); evaluation of unexplained hemolytic anemia; assessment of chronic pain, bone infarction, or organ dysfunction; family history of sickle cell disease; carrier screening before pregnancy; evaluation of acute pain episodes; assessment before surgery or anesthesia in at-risk populations.
    • Timing and Circumstances: Performed at birth as part of standard newborn screening; ordered during pregnancy for genetic counseling; performed when patients present with symptoms suggestive of sickle cell disease; used when screening high-risk ethnic populations (African, Mediterranean, Middle Eastern, or Asian descent); ordered prior to blood transfusion or organ transplantation.
  • Normal Range
    • Normal Result (Negative): No sickling observed; indicates absence of hemoglobin S; typical finding in individuals without sickle cell disease or sickle cell trait; red blood cells maintain normal biconcave shape under deoxygenation; reported as 'Negative' or 'No sickling'.
    • Positive Result (Abnormal): Sickling present; indicates presence of hemoglobin S; reported as 'Positive' or 'Sickling observed'; requires confirmatory testing with hemoglobin electrophoresis to determine if patient has sickle cell disease (SS) or sickle cell trait (AS).
    • Units of Measurement: Qualitative test (positive/negative); not a numerical value; based on microscopic observation of red blood cell morphology under conditions of reduced oxygen tension.
    • Result Interpretation: Negative = normal hemoglobin, no sickle disease or trait; Positive = presence of hemoglobin S, requires follow-up testing to confirm diagnosis and determine genotype (homozygous vs. heterozygous).
  • Interpretation
    • Positive Sickling Test with Hemoglobin Electrophoresis Showing SS (Homozygous): Diagnosis of sickle cell disease; patient has two copies of hemoglobin S gene; manifests severe hemolytic anemia and vaso-occlusive crises; at high risk for acute chest syndrome, stroke, splenic infarction, and organ damage; requires comprehensive disease management and treatment.
    • Positive Sickling Test with Hemoglobin Electrophoresis Showing AS (Heterozygous): Diagnosis of sickle cell trait; patient carries one copy of hemoglobin S gene; typically asymptomatic; generally has normal life expectancy; slight risk of complications under extreme conditions (high altitude, intense exercise); should receive genetic counseling for reproductive planning.
    • Negative Sickling Test: Rules out sickle cell disease and sickle cell trait; patient has normal hemoglobin; unlikely to have sickling-related complications; may still have other causes of anemia or hemolysis that require investigation.
    • Factors Affecting Results: Recent blood transfusion may delay positive results; severe anemia (very low red blood cell count) may produce false negatives; certain hemoglobinopathies (hemoglobin C disease, thalassemia) may produce variant patterns; patient age and hydration status; presence of polycythemia.
    • Clinical Significance: Positive result establishes genetic diagnosis and guides clinical management; determines need for prophylactic antibiotics, vaccines, and preventive care; identifies family members who may carry the gene; informs reproductive decision-making; guides treatment with disease-modifying therapies (hydroxyurea, L-glutamine, voxelotor, or gene therapy); predicts risk for specific complications.
  • Associated Organs
    • Primary Organ System: Hematologic system and bone marrow; red blood cells are the primary target of sickling; vascular system (capillaries and larger vessels affected by vaso-occlusion).
    • Commonly Associated Conditions: Sickle cell disease (severe hemolytic anemia); sickle cell trait (asymptomatic carrier state); vaso-occlusive crises (pain episodes); acute chest syndrome (pulmonary infarction); stroke and cerebral infarction; splenic infarction and autosplenectomy; renal dysfunction and chronic kidney disease; priapism; leg ulcers and osteonecrosis.
    • Diseases Diagnosed or Monitored: Sickle cell disease; sickle cell trait; hemoglobin SS disease; hemoglobin SC disease; sickle beta-thalassemia; other sickling hemoglobinopathies.
    • Potential Complications from Abnormal Results: Vaso-occlusive pain crises; acute chest syndrome with severe hypoxemia; stroke and transient ischemic attacks; splenic sequestration crisis; myocardial infarction; pulmonary hypertension; chronic organ damage (kidneys, heart, liver); increased infection risk from functional asplenia; hemolytic anemia leading to iron overload; bone necrosis (osteonecrosis); vision problems from retinal infarction.
  • Follow-up Tests
    • Confirmatory Testing: Hemoglobin electrophoresis (HPLC - High Performance Liquid Chromatography) to identify specific hemoglobin types and quantify percentages; determines whether patient has sickle cell disease (SS), sickle cell trait (AS), or other variant hemoglobins.
    • Initial Diagnostic Testing: Complete Blood Count (CBC) to assess hemoglobin level, hematocrit, reticulocyte count, and white blood cell differential; peripheral blood smear examination for target cells and nucleated RBCs; reticulocyte count to evaluate bone marrow response.
    • Baseline Organ Assessment: Comprehensive metabolic panel (kidney function, liver function, electrolytes); lactate dehydrogenase and bilirubin to quantify hemolysis; retinal examination for sickle retinopathy; transcranial doppler ultrasound to assess stroke risk; baseline echocardiogram; renal function testing.
    • Genetic Testing and Counseling: DNA-based genetic testing for definitive diagnosis; carrier status determination for family members; genetic counseling for reproductive planning; preimplantation genetic diagnosis (PGD) options discussion.
    • Ongoing Monitoring: Annual or biannual complete physical examination; regular CBC and comprehensive metabolic panel; annual kidney function assessment; biennial ophthalmologic examination; annual transcranial doppler ultrasound (in children); echocardiography every 2-3 years; monitoring during acute episodes and hospitalizations.
    • Supplementary Tests During Acute Illness: Blood cultures if fever present; chest X-ray for suspected acute chest syndrome; arterial blood gas analysis; lactate and LDH levels; bilirubin level; imaging of painful areas (MRI/CT) to detect infarction or osteonecrosis.
  • Fasting Required?
    • Fasting Requirement: No - Fasting is NOT required for the sickling test. This is a blood test that can be performed at any time of day regardless of food or fluid intake. Blood can be drawn on a random basis without patient preparation.
    • Special Patient Preparation Instructions: No specific fasting required; patient may eat and drink normally before test; no dietary restrictions apply; timing of meals does not affect test results; hydration status should be normal (adequate but not excessive); patient should avoid strenuous exercise immediately before phlebotomy to prevent hemoconcentration.
    • Medications: No medications need to be withheld before the sickling test; continue all regularly scheduled medications as prescribed; blood pressure medications, diabetes medications, and other chronic disease medications do not interfere with test interpretation; anticoagulants (warfarin, aspirin) may be continued unless patient is undergoing other procedures.
    • Additional Preparation for Newborns: Test performed on heel stick blood sample collected 24-48 hours after birth as part of routine newborn screening; no special preparation needed; minimal discomfort for infant; blood spot dried on filter paper card.
    • Considerations for Older Children and Adults: Standard venipuncture procedure used; patient should be seated or lying down during blood draw; no fasting effects on accuracy; if possible, avoid testing during acute vaso-occlusive crisis due to hemodynamic changes, though test remains valid; maintain normal hydration before draw.

How our test process works!

customers
customers